Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EY0779 / 2||LA / OT|
Administered by: Other Purchased by: ??
Symptoms: Pruritus, Rash
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Diagnostic Lab Data:
CDC 'Split Type': JPPFIZER INC2021663137
Write-up: Itching on both forearms; Skin eruption on both forearms; This is a spontaneous report from a contactable physician received via COVID-19 Vaccine Adverse Event Self-Reporting Solution (COVAES). The patient was a 27-year-old male. The most recent COVID-19 vaccine was administered in hospital. The patient didn''t receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no other medical history. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. On 13May2021 at 02:30PM, the patient previously received the first single dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number EW4811, Expiration date 31Jul2021) intramuscular at left arm for COVID-19 immunization. On 03Jun2021 at 03:00PM (the day of vaccination), the patient received the second single dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number: EY0779, Expiration Date: 31Aug2021) intramuscular at left arm for COVID-19 immunization. On 03Jun2021 at 03:30PM (30 minutes after the vaccination), the patient experienced Itching and Skin eruption on both forearms. The outcome of the event was recovered with treatment including injection of Solu-Medrol 125, Gaster 20, NEORESTAR 10, Sodium Chloride 50ml. Since the vaccination, the patient hasn''t been tested for COVID-19. The reporter started the events result in professional office or clinic visit.; Sender''s Comments: Based on temporal association, the causal relationship between BNT162B2 and the events pruritus and rash cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166